As artificial intelligence reshapes finance, we examine whether XRP's underlying technology is built to capitalize on the trend of 'agentic AI' handling transactions, or if its potential benefits remain speculative.
While the S&P 500 remains a core holding for many, actively managed and thematic ETFs offer a path to potentially superior returns. We analyze three Fidelity funds with distinct strategies—from U.S. tech dominance to international dividend income—that have historically beaten the market.
CNBC's Jim Cramer positions Alphabet as the potential 'only winner in AI,' suggesting its upcoming earnings may show it generating more revenue from AI than rival Meta Platforms.
Pioneer Bancorp reported a 33% surge in net income to $20.3 million for 2025, driven by loan growth and a new initiative to trade municipal bonds, as the regional bank expands its revenue streams.
As investors navigate a complex economic landscape, companies with significant insider ownership and robust earnings forecasts are drawing attention. We examine three ASX-listed firms where leadership's skin in the game aligns with ambitious growth projections.
Capital Management Corp's significant stake increase in investment bank Moelis & Company is being viewed by market observers as a strategic wager on a potential rebound in mergers and acquisitions activity.
Shares of the casino operator have pulled back from a four-year high in December, but a historically reliable long-term trendline suggests potential upside ahead of Thursday's earnings release.
As AMD prepares to report its Q4 2025 results, robust data center demand and ramping MI350 AI chip deployments paint a bullish picture. Yet, heavy investment costs and a history of post-earnings stock dips suggest investors should temper expectations.
M/I Homes' latest financial results reveal a year of softer earnings and margin pressure, even as the company completed a significant share repurchase. This mixed picture is prompting investors to reassess the homebuilder's near-term growth trajectory and the sustainability of its capital return strategy.
A newly disclosed DHS document reveals Palantir is providing generative AI to U.S. Immigration and Customs Enforcement to sort and summarize enforcement tips, highlighting the firm's deepening government integration just days before its Q4 earnings release.
While Boise Cascade's five-year total shareholder return of 110% has significantly outperformed its modest earnings growth, the building materials firm's recent stock slump raises questions about its valuation and future trajectory in a volatile market.
In a bold marketing move, telehealth company Hims & Hers is leveraging the Super Bowl's massive audience to spotlight healthcare inequality with its 'Rich People Live Longer' campaign. The push comes as the company expands into advanced diagnostics and treatments, while its stock navigates a significant valuation gap after recent volatility.
Palantir Technologies prepares to report Q4 2025 earnings after the bell, with Wall Street eyeing $1.33 billion in revenue and $0.23 EPS. The stock's recent 17.5% slump underscores investor anxiety over its premium valuation and the sustainability of its explosive commercial growth.
Barclays initiates coverage of 4D Molecular Therapeutics with an Overweight rating and a $33 price target, citing a favorable industry backdrop with potential M&A tailwinds and shifting focus away from drug pricing pressures. The gene therapy developer also outlined key clinical milestones expected through 2026.
ABB's shares surged 10% following its annual results, with earnings per share exceeding forecasts. Analysts have raised their price target to CHF 60.30 and project accelerated revenue growth ahead of industry peers.
New data reveals a two-horse race in mining sector legal advisory, with Webber Wentzel leading by total deal value and Blake Cassels & Graydon topping the charts by number of transactions in a year marked by megadeals.
As Nvidia prepares to report its fiscal Q4 earnings on February 25th, investors are weighing whether to buy ahead of the event. While the AI chip leader's long-term story remains compelling, a look at its recent post-earnings stock performance reveals a pattern that favors a measured approach over trying to time the market.
While Bed Bath & Beyond shares fell 13%, insiders who bought in the last year remain in profit, highlighting a potential disconnect between internal confidence and market sentiment.
Amid a resilient but mixed market, companies with significant insider ownership are drawing investor attention. We examine three firms—spanning crypto, consumer staples, and finance—where management's substantial equity stakes align with ambitious earnings growth forecasts of up to 124%.
Shares of the direct-to-consumer telehealth company Hims & Hers have been halved over the past six months, trading near $27. Investors are now weighing whether the steep sell-off presents a buying opportunity or signals deeper troubles ahead.
